He F, Qian Z, Lu L, Jiang J, Fan X, Wang Z, Xu X
Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Eye (Lond). 2016 Aug;30(8):1094-100. doi: 10.1038/eye.2016.106. Epub 2016 May 27.
ObjectiveThe objective of this study was to evaluate the clinical effects of modified partial pars plana vitrectomy together with phacoemulsification, intraocular lens (IOL) implantation, posterior capsulectomy, and zonulohyaloidectomy for patients with malignant glaucoma after trabeculectomy or cataract surgery.DesignRetrospective, cohort study.ParticipantsThirty consecutive patients (30 eyes) with malignant glaucoma after trabeculectomy surgery or ultrasonic phacoemulsification of cataract between January 2008 and September 2014 were enrolled.MethodsA retrospective analysis of 30 eyes with malignant glaucoma after trabeculectomy surgery for angle-closure glaucoma or ultrasonic phacoemulsification of cataract was performed. All patients underwent modified partial pars plana vitrectomy with zonulohyaloidectomy. Phacoemulsification and IOL implantation was performed in 25 patients with no previous cataract surgery. Pre-operative and post-operative ocular parameters were recorded in detail.Main outcome measuresClinical features, anterior chamber depth, best-corrected visual acuity, and intraocular pressure (IOP).ResultsIn these 30 patients, 25 had undergone trabeculectomy surgery and 5 had undergone cataract surgery. The mean axial length was 21.3±0.8 mm. After surgery, mean IOP decreased from 34±8.3 mm Hg to 10.5±4.1 mm Hg (P<0.001), and mean anterior chamber depth increased from 0.8±0.4 mm to 2.7±0.3 mm (P<0.001). No severe complications occurred.ConclusionsModified partial pars plana vitrectomy combined with phacoemulsification, IOL implantation, posterior capsulectomy, and zonulohyaloidectomy not only simplifies the process of traditional vitrectomy, but effectively resolves the ciliary block and corrects the misdirection of aqueous humor in malignant glaucoma.
目的
本研究的目的是评估改良式部分玻璃体切除术联合超声乳化、人工晶状体(IOL)植入、后囊切开术和晶状体悬韧带玻璃体切除术对小梁切除术后或白内障手术后恶性青光眼患者的临床疗效。
设计
回顾性队列研究。
研究对象
纳入2008年1月至2014年9月期间30例小梁切除术后或白内障超声乳化术后连续发生恶性青光眼的患者(30只眼)。
方法
对30只小梁切除术后闭角型青光眼或白内障超声乳化术后发生恶性青光眼的眼睛进行回顾性分析。所有患者均接受改良式部分玻璃体切除术联合晶状体悬韧带玻璃体切除术。25例既往未行白内障手术的患者接受了超声乳化和IOL植入。详细记录术前和术后的眼部参数。
主要观察指标
临床特征、前房深度、最佳矫正视力和眼压(IOP)。
结果
这30例患者中,25例行小梁切除术,5例行白内障手术。平均眼轴长度为21.3±0.8 mm。术后,平均眼压从34±8.3 mmHg降至10.5±4.1 mmHg(P<0.001),平均前房深度从0.8±0.4 mm增加至2.7±0.3 mm(P<0.001)。未发生严重并发症。
结论
改良式部分玻璃体切除术联合超声乳化、IOL植入、后囊切开术和晶状体悬韧带玻璃体切除术不仅简化了传统玻璃体切除术的过程,而且有效解决了睫状环阻滞并纠正了恶性青光眼中房水的错向。